Summary
58 / 100 · Bulios Score
What speaks for it
- Revenue grew by 34% a year over the last 3 years.
- You pay 9.8 USD for 1 USD of yearly profit, little for its sector.
What to watch
- Earnings per share fell by 30% a year over the last 3 years.
- It missed profit estimates 5 times in the last 6 quarters.
- Out of every 100 USD of revenue, only 6.9 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapToday you pay 9.8 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 34% a year over the last 3 years. Earnings per share fell by 30% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 40 USD
- Sales and administration 14 USD
- Taxes and other 39 USD
- Net profit 6.9 USD
Net profit, industry median (Insurance - Life) 10 USD
Out of every 100 USD of revenue, 6.9 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 8.65%
- Paid out of profit
- 85%
- Raised in a row
- 1 year
You receive $1.99 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
The company reports no revenue by region.
Reportable Segment brings in 100% of revenue.
Segments in detail